13 Jun 2017
A study presented at the 2017 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging reports that a novel peptide receptor radionuclide therapy significantly improves wellbeing for patients with malignant neuroendocrine tumours.
Call for nominations for Awards Committee Chair
30 Oct 2024
James M Tanner Award - 2025 nominations open
30 Oct 2024
Would you like to host the BSPED annual meeting?
21 Oct 2024